Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature

Oncology: International Journal of Cancer Research and Treatment
Published online: July 27, 2017
DOI: 10.1159/000478050

Utter K., Goldman C., Weiss S.A., Shapiro R.L., Berman R.S., Wilson M.A., Pavlick A.C., Osman I. 

Background: Metastatic melanoma of unknown primary (MUP) is uncommon, biologically ill defined, and clinically understudied. MUP outcomes are seldom reported in clinical trials. In this study, we analyze responses of MUP patients treated with systemic therapy in an attempt to inform treatment guidelines for this unique population. 

Seguir leyendo